alexa The FEF25-75 and its decline as a predictor of methacholine responsiveness in children.
Pulmonology

Pulmonology

Journal of Pulmonary & Respiratory Medicine

Author(s): Drewek R, Garber E, Stanclik S, Simpson P, Nugent M,

Abstract Share this page

Abstract BACKGROUND: Methacholine challenge (MCC) is an important diagnostic tool for asthma, especially in patients in whom routine pulmonary function testing (PFT) is normal or equivocal. The basis for a positive test per American Thoracic Society (ATS) guidelines is a methacholine concentration < or = 16 mg/mL that causes a 20\% decrease in forced expiratory volume in 1 second (FEV(1)) (termed the PC20 for FEV(1)). There is little information in the medical literature that utilizes other flow rates during MCC, including small airway function parameters such as the forced expiratory flow rate 25-75\% (FEF(25-75)). We question whether the FEF(25-75) may be a useful parameter to monitor during MCC and whether it may be predictive of a positive MCC. HYPOTHESIS: The baseline FEF(25-75) and its decline during a MCC are useful in the interpretation of a MCC. METHODS: We retrospectively analyzed all MCC performed at this institution between December 1998 and December 2006. Parameters reviewed included age, gender, race, weight, height, baseline PFT data including FVC, FEV(1), FEF(25-75), and forced expiratory time, methacholine PC20 for FEV(1), the relative changes from baseline for FEV(1) and FEF(25-75) during the MCC, and clinical symptoms during the MCC. RESULTS: A total of 532 MCC were completed during the 8-year study period in children 4 to 18 years of age. A total of 203 MCC (38\%) were positive (defined by a PC20 < or = 16 mg/mL) and 329 studies were negative (62\%). The baseline \% predicted FEF(25-75) in positive MCC was 82.4 +/- 21.9 vs. 98.7 +/- 21.3 in the negative studies (p < 0.001). The FEF(25-75)/FVC ratio in positive MCC was 0.82 +/- 0.21 vs. 0.97 +/- 0.23 in negative studies (p < 0.001). In the positive MCC, the decrease in FEF(25-75) was much faster and of much greater degree than in the negative challenges. When a significant reduction in FEF(25-75) was defined as greater than 10\% by the second concentration of methacholine (0.25 mg/mL), the sensitivity for a positive MCC was 63\%, the specificity was 71\%, the positive predictive value was 57\%, and the negative predictive value was 76\%. A comparison of the baseline FEF(25-75) to the PC20 for the positive MCCs revealed no statistical significance. CONCLUSIONS: The FEF(25-75) and its decline during a MCC appear to be useful information and potentially predictive of a positive MCC. We suggest that the forced expiratory flow rate 25-75\% (FEF(25-75)) be considered as an adjunct to the FEV(1) to define a positive study. This article was published in J Asthma and referenced in Journal of Pulmonary & Respiratory Medicine

Relevant Expert PPTs

Relevant Speaker PPTs

  • Shoude Jin
    Mechanisms of Chronic obstructive pulmonary disease and airway smooth muscle remodeling: the potential roles of Abhd2
    PDF Version
  • Alsayed Alnahal
    Urinary netrin-1 predict early ischemic acute kidney injury after cardiopulmonary bypass
    PPT Version | PDF Version
  • Ping Yang
    Chronic obstructive pulmonary disease (COPD) complicating early-stage lung cancer (LC)
    PDF Version
  • Gunilla Lindqvist
    Chronic obstructive pulmonary disease: A study of the relationship between patients’ feeling of guilt due to their belief of the disease being self inflicted
    PDF Version
  • Roger Mark Engel
    The effect of including manual therapy in the management of mild chronic obstructive pulmonary disease – a randomized controlled trial
    PDF Version
  • Rupal Patel Mansukhani
    Correlation of Medication Therapy in Chronic Obstructive Pulmonary Disease(COPD) Patients with 30-day Readmission Rates
    PPT Version | PDF Version
  • Hadeel Faisal Gad
    In-vitro analysis of cytokines responses of visceral leishmaniasis and pulmonary tuberculosis patients to homologous and heterologous antigen stimulation
    PPT Version | PDF Version
  • Xin Wang
    IL17 Pathway Involves Moderating Pulmonary Hypertension, a common complication of COPD, in Statins Therapy in Smoking Rats
    PPT Version | PDF Version

Recommended Conferences

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords